Most active investors · Last 30 days
Ranked by rounds participated in, from announcements in Sep 21, 2026 – Oct 20, 2026. Lead counts include only confirmed lead roles.
Browse by month
Details
New companies 1 · Follow-on 1
Stages: Series A 1, Series B 1
Kasvu Therapeutics €30M Series AVerda $189M Series B and additional investmentDetails
Details
New companies 2 · Follow-on 0
Stages: Growth 1, Seed 1
givestar £9M Growth fundingMetris Energy $5M SeedDetails
New companies 2 · Follow-on 0
Stages: Growth 2
givestar £9M Growth fundingProductive Machines Undisclosed Growth investmentDetails
New companies 2 · Follow-on 0
Stages: Undisclosed 2
Tempo Therapeutics ≤$2.3M NCI SBIR grantMolecular Targeting Technologies, Inc. $3.2M National Cancer Institute R01 grantDetails
New companies 2 · Follow-on 0
Stages: Seed 1, Series C+ 1
Basecamp Research $140M Series CTERASi €11M SeedDetails
New companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
EnginZyme SEK 75M Equity roundTERASi €11M SeedDetails
New companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
Sol $4M Funding roundProtein Pantry ₹90M SeedDetails
New companies 2 · Follow-on 0
Stages: Undisclosed 2
EnginZyme SEK 75M Equity roundHighLife €80M Financing roundDetails
Details
Details
Details
Details
Details
New companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Ande Undisclosed Series AAI Hospitality Group $7.5M SeedDetails
Details
Details
Details
Details
Details
Details
Details
Details
Details
New companies 0 · Follow-on 1
Stages: Undisclosed 1
SoVa Undisclosed Follow-on equity and bonds with warrantsDetails
New companies 1 · Follow-on 0
Stages: Undisclosed 1
SoVa Undisclosed Follow-on equity and bonds with warrantsDetails
Details
Details
“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.